Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy.

Summary, in English

Bone Scan Index (BSI) is a quantitative measurement of tumour burden in the skeleton calculated from bone scan images. When analysed at the time of diagnosis, it has been shown to provide prognostic information on survival in men with metastatic prostate cancer (PCa). In this study, we evaluated the prognostic value of BSI during androgen deprivation therapy (ADT).

• Author: Mariana Reza; Anders Bjartell; Mattias Ohlsson; Reza Kaboteh; Per Wollmer; Lars Edenbrandt; Elin Trägårdh
• Department/s: Nuclear medicine, Malmö; BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation; Urological cancer, Malmö; Department of Astronomy and Theoretical Physics - Has been reorganised; Clinical Physiology and Nuclear Medicine, Malmö; EpiHealth: Epidemiology for Health
• Publishing year: 2014
• Language: English
• Publication/Series: EJNMMI Research
• Volume: 4
• Full text: - 842 kB; Download statistics
• Links: http://www.ncbi.nlm.nih.gov/pubmed/25386390?dopt=Abstract; http://dx.doi.org/10.1186/s13550-014-0058-y
• Document type: Journal article
• Publisher: BioMed Central (BMC)
• Topic: Radiology, Nuclear Medicine and Medical Imaging
• Status: Published
• Research group: Nuclear medicine, Malmö; Urological cancer, Malmö; Clinical Physiology, Malmö
• ISBN/ISSN/Other: ISSN: 2191-219X